Abstract:C‐peptide, a byproduct of insulin synthesis believed to be biologically inert, is emerging as a multifunctional molecule. C‐peptide serves an anti‐inflammatory and anti‐atherogenic role in type 1 diabetes mellitus (T1DM) and early T2DM. C‐peptide protects endothelial cells by activating AMP‐activated protein kinase α, thus suppressing the activity of NAD(P)H oxidase activity and reducing reactive oxygen species (ROS) generation. It also prevents apoptosis by regulating hyperglycemia‐induced p53 upregulation and mitochondrial adaptor p66shc overactivation, as well as reducing caspase‐3 activity and promoting expression of B‐cell lymphoma‐2. Additionally, C‐peptide suppresses platelet‐derived growth factor (PDGF)‐beta receptor and p44/p42 mitogen‐activated protein (MAP) kinase phosphorylation to inhibit vascular smooth muscle cells (VSMC) proliferation. It also diminishes leukocyte adhesion by virtue of its capacity to abolish nuclear factor kappa B (NF‐kB) signaling, a major pro‐inflammatory cascade. Consequently, it is envisaged that supplementation of C‐peptide in T1DM might ameliorate or even prevent end‐organ damage. In marked contrast, C‐peptide increases monocyte recruitment and migration through phosphoinositide 3‐kinase (PI‐3 kinase)‐mediated pathways, induces lipid accumulation via peroxisome proliferator‐activated receptor γ upregulation, and stimulates VSMC proliferation and CD4+ lymphocyte migration through Src‐kinase and PI‐3K dependent pathways. Thus, it promotes atherosclerosis and microvascular damage in late T2DM. Indeed, C‐peptide is now contemplated as a potential biomarker for insulin resistance in T2DM and linked to increased coronary artery disease risk. This shift in the understanding of the pathophysiology of diabetes from being a single hormone deficiency to a dual hormone disorder warrants a careful consideration of the role of C‐peptide as a unique molecule with promising diagnostic, prognostic, and therapeutic applications.

Copper(II) Affects the Biochemical Behavior of Proinsulin C-peptide by Forming Ternary Complexes with Serum Albumin

Physiological effects and therapeutic potential of proinsulin C-peptide

Direct Competition of ATCUN Peptides with Human Serum Albumin for Copper(II) Ions Determined by LC-ICP MS

In vitro retardation and modulation of human insulin amyloid fibrillation by Fe3+ and Cu2+ ions

Mass Spectrometry Assisted Assignments of Binding and Cleavage Sites of Copper(ii) and Platinum(ii) Complexes Towards Oxidized Insulin B Chain.

The Physiology of Proinsulin C-Peptide: Unanswered Questions and a Proposed Model

Increased fatty acids in Type 1 Diabetes disrupts C‐peptide’s transport and downstream effect

C‐peptide in diabetes: A player in a dual hormone disorder?

Effects Of Proinsulin C-Peptide On Oxygen Transport, Uptake and Utilization In Insulinopenic Diabetic Subjects – A Review

Effect of different glycation agents on Cu(II) binding to human serum albumin, studied by liquid chromatography, nitrogen microwave-plasma atomic-emission spectrometry, inductively-coupled-plasma mass spectrometry, and high-resolution molecular-mass spectrometry

The Two Peptides Fragments of Goat Milk CSN1S2 Protein Blocked Insulin Receptor to Interact Ligand: In Silico Study

A Binuclear Complex Constituted by Diethyldithiocarbamate and Copper(i) Functions As a Proteasome Activity Inhibitor in Pancreatic Cancer Cultures and Xenografts.

Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action

An Investigation of Two Cu (II)‐Based Hybrid Materials: Physico‐Chemical Characterization, Theoretical Calculation and Evaluation of The Inhibitory Activities against Key Enzymes related to Diabetes and Obesity

Anti-Type II Diabetic Effects of Coix Seed Prolamin Hydrolysates: Physiological and Transcriptomic Analyses

Insights Into the Physiology of C-peptide

A proteomic approach to identify metalloproteins and metal-binding proteins in liver from diabetic rats

Influence of C-peptide on early glomerular changes in diabetic mice

A 3D copper (II) coordination polymer based on sulfanilic acid ligand (CP 1) for efficient biomolecular interaction with bovine serum albumin: spectroscopic, molecular modelling and DFT analysis.

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids

Research Progress of C-Peptide and Its Physiological Function